- Investing Ideas
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
100
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
100 companies
CG Oncology
Market Cap: US$5.6b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$65.81
7D
-0.08%
1Y
144.3%
Lipigon Pharmaceuticals
Market Cap: SEK 3.4m
A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.0058
7D
-12.1%
1Y
-96.1%
CollPlant Biotechnologies
Market Cap: US$10.8m
A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
CLGN
US$0.66
7D
8.2%
1Y
-75.1%
Viridian Therapeutics
Market Cap: US$2.9b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$28.20
7D
1.3%
1Y
92.2%
Vera Therapeutics
Market Cap: US$2.8b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
VERA
US$40.16
7D
4.8%
1Y
55.0%
Invivyd
Market Cap: US$404.1m
Engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States.
IVVD
US$1.56
7D
3.3%
1Y
153.5%
GNI Group
Market Cap: JP¥169.2b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥3,040.00
7D
7.0%
1Y
42.7%
Medigen Vaccine Biologics
Market Cap: NT$17.1b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$52.00
7D
15.3%
1Y
-1.5%
Aimed Bio
Market Cap: ₩3.5t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩54,400.00
7D
-3.4%
1Y
n/a
Healios K.K
Market Cap: JP¥49.5b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥367.00
7D
-7.6%
1Y
35.4%
Everest Medicines
Market Cap: HK$12.3b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$34.68
7D
0.8%
1Y
-35.7%
Active Biotech
Market Cap: SEK 117.0m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.045
7D
10.1%
1Y
-51.1%
Oryzon Genomics
Market Cap: €220.1m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.79
7D
1.1%
1Y
-15.7%
Diamyd Medical
Market Cap: SEK 2.0b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 14.66
7D
15.1%
1Y
75.4%
Anavex Life Sciences
Market Cap: US$253.9m
Operates as a biopharmaceutical company.
AVXL
US$2.88
7D
-31.4%
1Y
-69.8%
Unicycive Therapeutics
Market Cap: US$142.9m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$6.63
7D
-2.6%
1Y
5.8%
Praxis Precision Medicines
Market Cap: US$8.7b
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.
PRAX
US$302.69
7D
1.7%
1Y
679.1%
Arcellx
Market Cap: US$6.7b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$114.54
7D
0.03%
1Y
63.4%
Amicus Therapeutics
Market Cap: US$4.5b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$14.43
7D
0.4%
1Y
69.4%
Mirum Pharmaceuticals
Market Cap: US$5.3b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$90.17
7D
-1.6%
1Y
94.8%
Fennec Pharmaceuticals
Market Cap: US$205.7m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$6.17
7D
-17.4%
1Y
-4.6%
CStone Pharmaceuticals
Market Cap: HK$10.2b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$6.90
7D
-0.3%
1Y
97.1%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$11.6b
Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.
2595
HK$31.26
7D
20.2%
1Y
n/a
Captor Therapeutics Spolka Akcyjna
Market Cap: zł431.2m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł79.00
7D
0%
1Y
112.9%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.2b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥25.09
7D
-4.9%
1Y
-10.1%
Prelude Therapeutics
Market Cap: US$269.1m
A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
PRLD
US$3.24
7D
1.6%
1Y
375.2%
Day One Biopharmaceuticals
Market Cap: US$2.2b
A commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$21.40
7D
0.05%
1Y
161.3%
Savara
Market Cap: US$1.3b
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States.
SVRA
US$5.25
7D
1.7%
1Y
88.8%
Innate Pharma
Market Cap: €108.0m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.08
7D
-6.1%
1Y
-42.2%
Fortress Biotech
Market Cap: US$92.8m
A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
FBIO
US$2.88
7D
-8.3%
1Y
66.5%
Biovica International
Market Cap: SEK 106.8m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.34
7D
1.5%
1Y
-64.4%
Ionis Pharmaceuticals
Market Cap: US$12.0b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$74.24
7D
4.1%
1Y
134.0%
Benitec Biopharma
Market Cap: US$371.3m
A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
BNTC
US$10.81
7D
-6.0%
1Y
-21.2%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Protagonist Therapeutics
Market Cap: US$6.6b
Operates as a discovery and development company in the United States.
PTGX
US$104.31
7D
2.6%
1Y
111.0%
KalVista Pharmaceuticals
Market Cap: US$832.0m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
KALV
US$17.14
7D
10.7%
1Y
42.0%